Maryland Keeps the Trip Alive: State Psychedelics Task Force Extended Through 2027

Maryland is taking a major step toward expanding the "plant medicine" conversation. State lawmakers just greenlit a bill to extend the life of their psychedelics task force until the end of 2027. Originally set to wrap up sooner, this 17-person team—overseen by the Maryland Cannabis Administration—now has more time to map out a legal, regulated framework for substances like psilocybin and DMT. The goal is a multi-phase rollout, starting with therapeutic access and potentially leading to supervised adult use and even commercial sales.

This is a massive win for the community because it shows Maryland isn't just rushing into things; they’re building a sustainable, safe model that prioritizes equitable access. For tokers who value natural wellness, this legislative move signals a shift toward a more open and educated culture where natural alternatives are treated with respect rather than stigma. Keeping the task force active ensures that the focus remains on restorative justice and safety, setting the stage for a future where the "medicine" is accessible to everyone who needs it.